Ultra-High Throughput, High Purity Stem Cell Isolation

Information

  • Research Project
  • 6881884
  • ApplicationId
    6881884
  • Core Project Number
    R44DK065120
  • Full Project Number
    2R44DK065120-02A1
  • Serial Number
    65120
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/15/2003 - 21 years ago
  • Project End Date
    7/31/2006 - 17 years ago
  • Program Officer Name
    JENSEN, LEEANN T
  • Budget Start Date
    8/15/2005 - 18 years ago
  • Budget End Date
    7/31/2006 - 17 years ago
  • Fiscal Year
    2005
  • Support Year
    2
  • Suffix
    A1
  • Award Notice Date
    8/8/2005 - 18 years ago
Organizations

Ultra-High Throughput, High Purity Stem Cell Isolation

[unreadable] DESCRIPTION (provided by applicant): There is considerable evidence for the application of transplantation of Hematopoietic and Mesenchymal Stem Cells in the treatment of a wide range of cancers including lymphoma, neuroblastoma, and multiple myeloma. In addition, HSC/MSC therapies can be applied to reconstitute the immune system, regenerate damaged tissues, and deliver genes to repair damaged cells for many auto-immune diseases such as diabetes, rheumatoid arthritis, and systemic lupus erythematosis. One of the major roadblocks in the successful application of transplant treatments is the difficulty in rapidly obtaining a pure sample of stem cells in the harvested sample. [unreadable] This ultimate objective of our research is the development of an ultra-high throughput high-purity cell sorter, Gigasort, for stem cell harvesting. The cell sorter consists of several parallel microfluidic channels that combine to produce throughput that is expected to be at least 10x that of current generation cell sorters in practice, without compromising sample purity. The current proposal is aimed at developing a multichannel sorter test bed that is extendable in the number of parallel channels used. We will build the test bed and experimentally measure the sorting performance for fluorescent beads and cells, including cells harvested from blood. [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R44
  • Administering IC
    DK
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    710818
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:710818\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CYTONOME, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    WATERTOWN
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    024722234
  • Organization District
    UNITED STATES